Paul B. Cleveland
Mr. Cleveland is the chairman of Adverum’s board of directors. Previously at Adverum, he has served as executive chairman, chief executive officer, and director, which he was appointed in December 2015. Mr. Cleveland previously served as the chief executive officer of Celladon Corporation. He has more than 20 years of leadership experience, including management and operational experience across the biotechnology industry. Mr. Cleveland has held positions at multiple public biotechnology companies, including chief executive officer, president, chief financial officer and board member, as well as chief operating officer at a venture capital firm. Mr. Cleveland received a B.A. from Washington University in St. Louis and a J.D. from the Northwestern University School of Law.